Oncology News Today

Latest news

Breast

New research to investigate what stops black African and Caribbean women taking vital breast cancer medication

by Catherine Bontoft

26 July 2024

Blood

NICE issues draft guidance on bispecific antibody TECVAYLI®▼(teclistamab) for eligible patients with relapsed and refractory multiple myeloma after three treatments

25 July 2024

General News

Cancer care to benefit from BCU research into surgery on a patient’s digital replica

24 July 2024

General News

Hospital cancer unit receives a Macmillan Quality Environment Mark

23 July 2024

Breast

MHRA approves first-in-class breast cancer drug

26 July 2024

Breast

New research to investigate what stops black African and Caribbean women taking vital breast cancer medication

by Catherine Bontoft

26 July 2024

The Institute of Cancer Research, London, welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA) for treating the most common type of advanced breast cancer.

MHRA approves first-in-class breast cancer drug

by Catherine Bontoft

26 July 2024

Researchers will investigate the relationship between breastfeeding and breast cancer, thanks to new funding from Breast Cancer Now.

New research to investigate why breastfeeding reduces the risk of developing breast cancer

by Catherine Bontoft

25 June 2024

Image: Dr Isaac Garcia-Murillas. Credit: Institute of Cancer Research

New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse

by Catherine Bontoft

5 June 2024

Colorectal

Bowel cancer cells have the ability to regulate their growth using a genetic on-off switch to maximise their chances of survival, a phenomenon that’s been observed for the first time by researchers at UCL and University Medical Center Utrecht.

Lung

Swimming microbots deliver cancer-fighting drugs to metastatic lung tumours in mice

by Catherine Bontoft

26 June 2024

Pfizer Ltd has announced longer-term follow-up results from the phase 3 CROWN trial evaluating Lorviqua® q (lorlatinib) versus Xalkori® (crizotinib) in participants with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

Pfizer’s Lorviqua® q (lorlatinib) CROWN study shows majority of patients with ALK-positive advanced lung cancer living beyond five years without disease progression

by Catherine Bontoft

5 June 2024

linithink’s AI technology, capable of reading and understanding medical records, has been used successfully by a research team at Barts Health NHS Trust to predict which patients might be at risk of lung cancer in a first-of-its-kind project funded by AstraZeneca.

AI could predict risk of lung cancer at an earlier stage, new research shows

by Catherine Bontoft

3 June 2024

University of Leicester specialist is recognised for a lifetime’s devotion to cancer research

by Catherine Bontoft

22 May 2024

Prostate

Transformative education on offer at International Urology Cancer Summit

by Catherine Bontoft

3 July 2024

Time is running out to submit abstracts to the second International Urology Cancer Summit.

Last call for abstracts for International Urology Cancer Summit

by Catherine Bontoft

10 June 2024

Dheeresh (right) and his brother Joel (left) at The Banham Marsden March at Sutton 2022. Credit: Dheeresh Turnbull.

Prostate cancer spit test better for men with high genetic risk than standard blood test

by Catherine Bontoft

5 June 2024

Brachytherapy Nurse Specialist Suzanne Langley has become the latest clinician in Royal Surrey NHS Foundation Trust's Stokes Centre for Urology to be appointed a Prostate Cancer UK Champion.

Prostate Cancer UK Champion reveals details of new project

by Catherine Bontoft

3 June 2024

Guidelines

Access key guidelines for oncology healthcare professionals

Resources

All the major resources from the world of oncology

Podcasts

We bring you informative podcasts with UK oncology experts

Events

Don't miss the latest oncology events in the UK

Contact us

By submitting your request, you are confirming that you have read and agree to our Privacy Policy.

Latest news

New research to investigate what stops black African and Caribbean women taking vital breast cancer medication

NICE issues draft guidance on bispecific antibody TECVAYLI®▼(teclistamab) for eligible patients with relapsed and refractory multiple myeloma after three treatments

Cancer care to benefit from BCU research into surgery on a patient’s digital replica

Hospital cancer unit receives a Macmillan Quality Environment Mark

MHRA approves first-in-class breast cancer drug

Breast

New research to investigate what stops black African and Caribbean women taking vital breast cancer medication

MHRA approves first-in-class breast cancer drug

New research to investigate why breastfeeding reduces the risk of developing breast cancer

New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse

Colorectal

Bowel cancer turns genetic switches on and off to outwit the immune system

Trial at UCLH aims to prevent colorectal cancer from coming back

Transformative education on offer at International Urology Cancer Summit

Mum-of-three cancer free after clinical trial at The Christie

Lung

Swimming microbots deliver cancer-fighting drugs to metastatic lung tumours in mice

Pfizer’s Lorviqua® q (lorlatinib) CROWN study shows majority of patients with ALK-positive advanced lung cancer living beyond five years without disease progression

AI could predict risk of lung cancer at an earlier stage, new research shows

University of Leicester specialist is recognised for a lifetime’s devotion to cancer research

Prostate

Transformative education on offer at International Urology Cancer Summit

Last call for abstracts for International Urology Cancer Summit

Prostate cancer spit test better for men with high genetic risk than standard blood test

Prostate Cancer UK Champion reveals details of new project

Guidelines

Resources

Podcasts

Events

Contact us

Registration Information

Are you a healthcare professional?